PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein: An Innovative Tool for Illuminating Precision Diagnosis and Treatment of Epithelial-Derived Tumors

PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein is a high-performance fluorescently labeled fusion protein that plays a significant role in the research and therapeutic development of various epithelial-derived tumors, including colorectal cancer, gastric cancer, and lung cancer.

  • Recent Advances
  • Product Information
Recent Advances

PE-Labeled CEACAM-5/CD66e Fc&Avi Tag protein is a high-performance fluorescently labeled fusion protein that plays a pivotal role in the research and therapeutic development of various epithelial-derived tumors, including colorectal cancer, gastric cancer, and lung cancer. This article provides an in-depth analysis of the molecular structure and unique advantages of this protein, as well as a detailed explanation of its significant application value in tumor diagnosis, targeted therapy, and immunotherapy.

 

I. Molecular Structure Analysis: What is PE-Labeled CEACAM-5/CD66e Fc&Avi Tag Protein?

 

This is an advanced biological probe that integrates targeting specificity, detection sensitivity, and application flexibility, composed of four meticulously designed core elements:

 

  1. CEACAM-5/CD66e Targeting Domain
    • Biological Nature: A member of the carcinoembryonic antigen family, a cell surface glycoprotein
    • Expression Characteristics:
      • Normal Tissues: Low expression in epithelial cells of the gastrointestinal, respiratory, and urinary tracts
      • Tumor Tissues: Aberrantly high expression in various epithelial-derived malignancies
    • Pathological Significance: A key regulator promoting tumor cell proliferation, invasion, and metastasis
  2. Fc Chimera Domain
    • Engineering Advantage: Genetic fusion of human IgG Fc fragment with the extracellular domain of CEACAM-5
    • Functional Features:
      • Stable Dimerization: Maintains the natural conformation and biological function of CEACAM-5
      • Efficient Purification: Protein A/G affinity chromatography ensures high-purity preparation
      • Signal Amplification: Supports secondary antibody-mediated detection signal enhancement
  3. Avi Tag Labeling System
    • Technical Characteristics: A 15-amino acid biotinylation tag
    • Unique Advantages:
      • Precise Labeling: Site-specific biotinylation catalyzed by BirA enzyme
      • Ultra-High Affinity: Irreversible binding to streptavidin
      • Application Diversity: Supports various detection platforms and immobilization needs
  4. PE Fluorescent Reporter System
    • Optical Properties: Phycoerythrin, with a large Stokes shift
    • Performance Advantages:
      • Ultra-High Brightness: Each PE molecule carries multiple fluorescent chromophores
      • Exceptional Sensitivity: Ideal for detecting low-abundance antigens
      • Multicolor Compatibility: Easily paired with other fluorescent dyes

 

II. Technical Advantages and Application Scenarios

 

Core Technical Advantages

Ultra-Sensitive Detection: PE provides an exceptional signal-to-noise ratio, significantly lowering the detection limit

High-Specificity Binding: Maintains the complete biological function and binding properties of CEACAM-5

Application Flexibility: Supports multi-scenario applications from basic research to clinical translation

 

Major Application Directions

  1. High-Sensitivity Flow Cytometry
    • Precise quantification of CEACAM-5 expression on tumor cell surfaces
    • Identification and sorting of circulating tumor cells
    • Dynamic monitoring of target expression before and after treatment
  2. Immunotherapy Product Quality Control
    • Validation of CAR-T cell surface receptor expression
    • Assessment of antibody drug binding activity
    • Consistency testing between batches of therapeutic products
  3. Drug Screening and Optimization
    • Rapid determination of candidate antibody affinity
    • Competitive binding analysis
    • Epitope identification and characterization
  4. Advanced Imaging Research
    • Spatial localization of CEACAM-5 in tissue sections
    • Study of tumor heterogeneity
    • Tracking of therapeutic drug distribution in vivo

 

III. Disease Association: Key Areas in the Diagnosis and Treatment of Epithelial-Derived Tumors

 

1. Colorectal Cancer (Core Application Area)

Diagnostic Value

Serum Biomarker: CEACAM-5 is an important serum tumor marker for colorectal cancer

Prognostic Assessment: Expression levels are significantly correlated with disease stage and prognosis

Recurrence Monitoring: Postoperative serum level monitoring predicts recurrence risk

 

Therapeutic Applications

Targeted Drug Development:

Target validation for antibody-drug conjugates

Evaluation of binding properties for bispecific antibodies

Treatment Monitoring:

Early prediction of treatment response

Study of resistance mechanisms

 

2. Gastric Cancer and Esophageal Cancer

Clinical Significance

Diagnostic Value: Aids in the diagnosis and staging of gastric cancer

Therapeutic Target: Multiple CEACAM-5-targeted therapies are in clinical research

Prognostic Indicator: Expression levels correlate with lymph node metastasis and survival rates

 

Research Progress

Development of Novel Therapies: Research on specific CAR-T cell therapies

Combination Therapy: Exploration of synergistic effects with traditional chemotherapy

Diagnostic Innovation: CEACAM-5-based liquid biopsy technologies

 

3. Non-Small Cell Lung Cancer

Expression Characteristics

Tissue Distribution: High expression in lung adenocarcinoma

Clinical Value:

Differential diagnostic indicator

Prognostic factor

Exploration of therapeutic targets

 

Therapeutic Exploration

Targeted Therapy: Development of specific antibody drugs

Immunotherapy: Research on CAR-T cell therapies

Diagnostic Imaging: Development of radiolabeled probes

 

4. Breast Cancer and Other Tumors

Breast Cancer: Higher expression in triple-negative breast cancer

Pancreatic Cancer: Potential diagnostic and therapeutic target

Thyroid Cancer: Exploratory targeted therapy research

 

IV. Cutting-Edge Progress and Future Prospects

 

Current Research Hotspots

  1. Development of Novel Immunotherapies
    • Optimization of next-generation CAR-T cells
    • Development of TCR-mimicking antibodies
    • Design of bispecific adapters
  2. Exploration of Theranostics
    • Targeting-diagnosis integrated probes
    • Early prediction biomarkers for treatment response
    • Development of personalized treatment strategies
  3. Research on Resistance Mechanisms
    • Mechanisms of resistance to targeted therapies
    • Optimization of combination therapy strategies
    • Discovery of biomarkers

 

Technological Development Trends

  1. Integration of Multi-Omics
    • Single-cell level analysis of CEACAM-5 expression
    • Spatial transcriptome correlation studies
    • Proteomic feature analysis
  2. Acceleration of Clinical Translation
    • Development of companion diagnostics
    • New methods for treatment monitoring
    • Establishment of prognostic prediction models
  3. Expansion of Innovative Applications
    • Novel drug delivery systems
    • Development of molecular imaging probes
    • Study of microenvironment regulation

 

Summary

 

The core value of PE-Labeled CEACAM-5/CD66e Fc&Avi Tag protein is reflected in:

 

  1. Research Foundation
    • Provides a key tool for the biological study of CEACAM-5
    • A standardized platform for targeted therapy development
  2. Diagnostic Innovation
    • Promotes CEACAM-5-based precision diagnostics
    • An important support for liquid biopsy technologies
  3. Therapeutic Breakthrough
    • Accelerates the development of novel targeted and immunotherapies
    • A reliable guarantee for the quality control of therapeutic products
  4. Translational Bridge
    • Connects basic research with clinical applications
    • Drives the development of personalized medicine

 

With the deepening development of precision medicine in oncology, this high-performance protein tool will undoubtedly play an increasingly important role in the research and treatment of epithelial-derived tumors such as colorectal cancer, gastric cancer, and lung cancer, offering new hope for improving patient prognosis.

 

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Target proteins | membrane proteins | cytokines | enzymes | viral antigens | protein customization
Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience
Nanjing UA Biotechnology Co., Ltd. Email:order@ua-bio.com Phone:+86-25-56221161
公众号
Product Information
The Last The Next